Trade Tarsus Pharmaceuticals, Inc. - TARS CFD

Trading Conditions

• Type: CFD
• Spread: 0.18
• Long position overnight funding adjustment: -0.02157%
• Short position overnight funding adjustment: -0.00065%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 0.1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 68.07
• Open: 68.13
• 1-Year Change: 44.5%
• Day's Range: 67.43 - 68.57

What is Tarsus Pharmaceuticals, Inc. (TARS)?

Tarsus Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapies for ophthalmic conditions. The company specializes in treatments addressing diseases and disorders affecting the eyes, including dry eye disease and other ocular surface disorders. Tarsus Pharmaceuticals engages in research and development activities to advance its pipeline of pharmaceutical candidates. Its approach involves leveraging scientific expertise and clinical development to bring novel therapies to market. The company collaborates with healthcare professionals and regulatory agencies to ensure the safety and efficacy of its products. It operates within the pharmaceutical industry, contributing to the advancement of eye care treatments.

Tarsus Pharmaceuticals, Inc. Stock Price Today: Live Overview

The price today is shaped by trading dynamics, as Tarsus Pharmaceuticals, Inc. reaches $68.10. The price has varied within $66.61 and $68.68, with a daily change percentage of 0%.

FAQ: Tarsus Pharmaceuticals, Inc. (TARS)

What is the current price of TARS stock?

The latest price stands at $68.10.

Does TARS pay dividends?

Tarsus Pharmaceuticals, Inc. does not pay dividends.

Does TARS have a formal corporate presence or regional headquarters in the UAE?

Tarsus Pharmaceuticals, Inc. does not have an official office or subsidiary in the UAE and operates through local partners.

What is TARS best known for?

The company is most famous for developing treatments for ophthalmic diseases.

What assets are typically shown together with TARS?

Commonly shown alongside TARS: Puretech Health plc, Intellia Therapeutics Inc, Curis, Inc.